ZNF571
gene geneOn this page
Also known as HSPC059
Summary
ZNF571 (zinc finger protein 571, HGNC:25000) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 571 (Q7Z3V5). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleus.
Source: NCBI Gene 51276 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_016536
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25000 |
| Approved symbol | ZNF571 |
| Name | zinc finger protein 571 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HSPC059 |
| Ensembl gene | ENSG00000180479 |
| Ensembl biotype | protein_coding |
| Entrez | 51276 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 protein_coding
ENST00000358744, ENST00000451802, ENST00000590390, ENST00000590751, ENST00000593133, ENST00000866821, ENST00000866822, ENST00000931148, ENST00000942645
RefSeq mRNA: 3 — MANE Select: NM_016536
NM_001290314, NM_001321272, NM_016536
CCDS: CCDS12505
Canonical transcript exons
ENST00000451802 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001057020 | 37586668 | 37586745 |
| ENSE00001433241 | 37583971 | 37584097 |
| ENSE00001675163 | 37594741 | 37594792 |
| ENSE00002752678 | 37564260 | 37566291 |
Expression profiles
Bgee: expression breadth ubiquitous, 205 present calls, max score 92.08.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.8075 / max 54.2742, expressed in 1050 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180718 | 2.5402 | 1037 |
| 180721 | 0.1566 | 64 |
| 180720 | 0.0924 | 46 |
| 180719 | 0.0184 | 11 |
Top tissues by expression
279 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 92.08 | gold quality |
| oocyte | CL:0000023 | 89.70 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.56 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 86.28 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 85.39 | gold quality |
| thyroid gland | UBERON:0002046 | 83.70 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.87 | gold quality |
| sural nerve | UBERON:0015488 | 80.35 | gold quality |
| ganglionic eminence | UBERON:0004023 | 79.50 | gold quality |
| calcaneal tendon | UBERON:0003701 | 78.55 | gold quality |
| cortical plate | UBERON:0005343 | 78.49 | gold quality |
| right testis | UBERON:0004534 | 77.99 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.88 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 77.18 | gold quality |
| left testis | UBERON:0004533 | 77.14 | gold quality |
| adenohypophysis | UBERON:0002196 | 76.52 | gold quality |
| islet of Langerhans | UBERON:0000006 | 76.35 | gold quality |
| right uterine tube | UBERON:0001302 | 76.32 | gold quality |
| left ovary | UBERON:0002119 | 76.26 | gold quality |
| testis | UBERON:0000473 | 76.10 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 75.90 | gold quality |
| ventricular zone | UBERON:0003053 | 75.84 | gold quality |
| right ovary | UBERON:0002118 | 75.77 | gold quality |
| right adrenal gland | UBERON:0001233 | 75.60 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 75.36 | gold quality |
| pituitary gland | UBERON:0000007 | 75.33 | gold quality |
| cerebellar cortex | UBERON:0002129 | 75.31 | gold quality |
| popliteal artery | UBERON:0002250 | 75.17 | gold quality |
| tibial artery | UBERON:0007610 | 75.16 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 75.02 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-109979 | yes | 269.27 |
| E-MTAB-7249 | yes | 11.14 |
| E-ANND-3 | no | 4.54 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| HP | |
| TRIM28 |
miRNA regulators (miRDB)
39 targeting ZNF571, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-7157-5P | 99.66 | 69.33 | 1829 |
| HSA-MIR-651-5P | 99.64 | 68.49 | 1104 |
| HSA-MIR-298 | 99.63 | 67.56 | 1916 |
| HSA-MIR-4310 | 99.59 | 68.84 | 2527 |
| HSA-MIR-32-3P | 99.36 | 68.20 | 2517 |
| HSA-MIR-4477B | 99.23 | 70.49 | 1733 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-2054 | 99.20 | 68.89 | 1699 |
| HSA-MIR-4528 | 99.18 | 69.77 | 1936 |
| HSA-MIR-4699-5P | 98.99 | 67.50 | 1210 |
| HSA-MIR-4801 | 98.96 | 69.42 | 2096 |
| HSA-MIR-1245B-5P | 98.88 | 66.55 | 576 |
| HSA-MIR-3142 | 98.88 | 66.09 | 529 |
| HSA-MIR-4716-5P | 98.82 | 68.57 | 1168 |
| HSA-MIR-16-1-3P | 98.70 | 69.23 | 1538 |
| HSA-MIR-4303 | 98.01 | 68.13 | 2304 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 571 — Q7Z3V5 (reviewed: Q7Z3V5)
All UniProt accessions (3): Q7Z3V5, K7ELU5, K7ERB9
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (3): NP_001277243, NP_001308201, NP_057620* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (26 total): zinc finger region 17, sequence variant 5, sequence conflict 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z3V5-F1 | 75.02 | 0.36 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 82 (showing top):
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP, STAT1_02, YKACATTT_UNKNOWN, GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, OKUMURA_INFLAMMATORY_RESPONSE_LPS, STAT1_03, ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN, IL15_UP.V1_DN, IL2_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, NCOA6_TARGET_GENES, PAX3_TARGET_GENES, SKP2_TARGET_GENES, ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
264 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF571 | C12orf42 | Q96LP6 | 475 |
| ZNF571 | KAT8 | Q9H7Z6 | 443 |
| ZNF571 | NKAPL | Q5M9Q1 | 323 |
| ZNF571 | SHISA6 | Q6ZSJ9 | 310 |
| ZNF571 | GPR75 | O95800 | 305 |
| ZNF571 | F6S8H2 | F6S8H2 | 295 |
| ZNF571 | PCDHAC2 | Q9Y5I4 | 290 |
| ZNF571 | TEX261 | Q6UWH6 | 270 |
| ZNF571 | TBC1D2 | Q9BYX2 | 270 |
| ZNF571 | PCDHA1 | Q9Y5I3 | 270 |
| ZNF571 | TRIM58 | Q8NG06 | 268 |
| ZNF571 | ZNF646 | O15015 | 267 |
| ZNF571 | PGBD1 | Q96JS3 | 264 |
| ZNF571 | TMEM100 | Q9NV29 | 259 |
| ZNF571 | AJAP1 | Q9UKB5 | 259 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF571 | HERC1 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF571 | CBX3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): CSTF2T (Affinity Capture-MS), HERC1 (Affinity Capture-MS), ZNF571 (Affinity Capture-RNA), ZNF571 (Affinity Capture-RNA), CSTF2T (Affinity Capture-MS), HERC1 (Affinity Capture-MS), ZNF571 (Affinity Capture-MS)
ESM2 similar proteins: A0JNB1, A6QLU5, O75123, O75820, P10076, P10755, P16374, P17031, P17097, P17141, P51814, Q02975, Q08ER8, Q14588, Q14590, Q32KN0, Q3V080, Q4V8A8, Q5CZA5, Q5R4K8, Q5R5Q6, Q5R9S5, Q5RBX0, Q61751, Q6GQR8, Q6P560, Q6ZMS4, Q7TSH9, Q7TSI0, Q7Z3I7, Q7Z3V5, Q8BLB0, Q8N141, Q8N184, Q8N823, Q8N8J6, Q8N9F8, Q8TBZ5, Q8TF47, Q96ND8
Diamond homologs: A0A1W2PQL4, A2RRD8, A2VDQ7, A6NHJ4, A6NK75, A6NN14, A6NNF4, A6NP11, B4DX44, B4DXR9, E9PW05, O14628, O43345, O75290, O75346, O75373, O75820, P0CB33, P0CJ79, P0DKX0, P10755, P17032, P17035, P52738, Q02386, Q03923, Q03936, Q05481, Q08AN1, Q09FC8, Q0VGE8, Q14586, Q14593, Q147U1, Q15928, Q3MIS6, Q3SXZ3, Q494X3, Q4R6C2, Q5HY98
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1193 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:37583964:ATCTT:A | donor_loss | 1.0000 |
| 19:37583966:CTTA:C | donor_loss | 1.0000 |
| 19:37583967:TTACC:T | donor_loss | 1.0000 |
| 19:37583968:TA:T | donor_loss | 1.0000 |
| 19:37583969:A:AC | donor_gain | 1.0000 |
| 19:37583969:AC:A | donor_gain | 1.0000 |
| 19:37583970:C:CC | donor_gain | 1.0000 |
| 19:37583970:CC:C | donor_gain | 1.0000 |
| 19:37584095:CAA:C | acceptor_gain | 1.0000 |
| 19:37586746:C:CC | acceptor_gain | 1.0000 |
| 19:37566289:AGTCT:A | acceptor_loss | 0.9900 |
| 19:37566290:GTC:G | acceptor_loss | 0.9900 |
| 19:37566292:C:CC | acceptor_gain | 0.9900 |
| 19:37583970:CCCA:C | donor_gain | 0.9900 |
| 19:37584098:C:CC | acceptor_gain | 0.9900 |
| 19:37586666:A:AC | donor_gain | 0.9900 |
| 19:37586667:C:CC | donor_gain | 0.9900 |
| 19:37586741:CAGTG:C | acceptor_gain | 0.9900 |
| 19:37586744:TG:T | acceptor_gain | 0.9900 |
| 19:37594219:CT:C | donor_gain | 0.9900 |
| 19:37594737:TCACC:T | donor_loss | 0.9900 |
| 19:37594738:CACCT:C | donor_loss | 0.9900 |
| 19:37594739:ACCTG:A | donor_loss | 0.9900 |
| 19:37594740:C:G | donor_loss | 0.9900 |
| 19:37566287:CAAGT:C | acceptor_gain | 0.9800 |
| 19:37566293:T:A | acceptor_loss | 0.9800 |
| 19:37583951:A:AC | donor_gain | 0.9800 |
| 19:37586743:GTG:G | acceptor_gain | 0.9800 |
| 19:37591444:C:CA | acceptor_gain | 0.9800 |
| 19:37594218:A:AC | donor_gain | 0.9800 |
AlphaMissense
4076 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:37565480:A:C | F316L | 0.996 |
| 19:37565480:A:T | F316L | 0.996 |
| 19:37565482:A:G | F316L | 0.996 |
| 19:37565648:A:C | F260L | 0.995 |
| 19:37565648:A:T | F260L | 0.995 |
| 19:37565650:A:G | F260L | 0.995 |
| 19:37565396:A:C | F344L | 0.994 |
| 19:37565396:A:T | F344L | 0.994 |
| 19:37565398:A:G | F344L | 0.994 |
| 19:37565564:A:C | F288L | 0.994 |
| 19:37565564:A:T | F288L | 0.994 |
| 19:37565566:A:G | F288L | 0.994 |
| 19:37564895:A:C | F511L | 0.993 |
| 19:37564895:A:T | F511L | 0.993 |
| 19:37564897:A:G | F511L | 0.993 |
| 19:37565228:A:C | F400L | 0.993 |
| 19:37565228:A:T | F400L | 0.993 |
| 19:37565230:A:G | F400L | 0.993 |
| 19:37565455:G:C | H325D | 0.993 |
| 19:37565463:A:G | L322P | 0.992 |
| 19:37564811:A:C | F539L | 0.991 |
| 19:37564811:A:T | F539L | 0.991 |
| 19:37564813:A:G | F539L | 0.991 |
| 19:37565144:A:C | F428L | 0.991 |
| 19:37565144:A:T | F428L | 0.991 |
| 19:37565146:A:G | F428L | 0.991 |
| 19:37565211:A:G | L406P | 0.991 |
| 19:37565732:A:C | F232L | 0.991 |
| 19:37565732:A:T | F232L | 0.991 |
| 19:37565734:A:G | F232L | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000105307 (19:37567646 G>T), RS1000136509 (19:37567366 C>T), RS1000367235 (19:37588246 T>A), RS1000381410 (19:37581350 C>G,T), RS1000412419 (19:37580952 C>T), RS1000497753 (19:37594309 G>A), RS1000569991 (19:37593994 C>A), RS1000580173 (19:37573617 A>G), RS1000729152 (19:37574168 T>A), RS1000732555 (19:37566219 C>T), RS1000800438 (19:37587856 C>A,T), RS1001110696 (19:37569163 G>A), RS1001141692 (19:37568799 T>C,G), RS1001164030 (19:37580578 G>A), RS1001203604 (19:37567018 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_55 | Refractive error | 7.000000e-09 |
| GCST012048_20 | Triglyceride levels | 2.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004530 | triglyceride measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | increases expression | 2 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| geraniol | increases expression | 1 |
| methylparaben | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Vorinostat | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Aflatoxin M1 | decreases expression | 1 |
| Gold Compounds | decreases expression | 1 |
| Magnetite Nanoparticles | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW65 | HEK293 eGFP-ZNF571 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.